Resolution of Cardiogenic Shock Using Echocardiography-Guided Pacing Optimization in Intensive Care: A Case Series*

Objective:Inotropic and vasopressor drugs are routinely used in critically ill patients to maintain adequate blood pressure and cardiac output in patients with cardiogenic shock although potentially at the expense of increasing myocardial oxygen demand. Pacing optimization has been demonstrated as effective in reducing catecholamine requirements in patients with chronic heart failure by improving cardiac efficiency; however, there are no reports relating to the effectiveness of pacemaker optimization on cardiac output in critically ill patients with cardiogenic shock in the intensive care. Data Sources:Retrospective data analysis. Study Selection:Twenty-bed adult tertiary cardiothoracic ICU, university hospital. Data Extraction:Eight sequential patients receiving dual chamber pacemaker with DDD modality with cardiogenic shock and hemodynamic instability refractory to catecholamines underwent echocardiography-guided pacemaker optimization of cardiac output. An iterative method with Doppler echocardiography was used to assess changes in cardiac output, left ventricular filling time, ejection time, total isovolumic time, mitral regurgitation, ejection fraction, and blood pressure at different increments of heart rate, and atrioventricular and interventricular delay. All results are shown as median (minimum/maximum level) or mean ± SD. Data Synthesis:Using echocardiography-guided pacemaker optimization on cardiac output, the cardiac output increased from 3.2 (2.3/3.8) to 5.7 L/min (4.85/7.1) and cardiac index from 1.64 (1.1/1.9) to 2.68 L/min/m2 (2.1/3.2) and the total isovolumic time reduced from 22.8 to normal values (<14). In association, the glomerular filtration rate increased significantly except in one patient with stage IV chronic kidney disease. All inotropes and vasopressors were discontinued within 12 hours of pacemaker optimization on cardiac output, and all patients were discharged from the ICU within 1 week. Conclusions:Echocardiography-guided pacemaker optimization of cardiac output is a feasible bedside therapeutic option, which should be considered when standard medical treatments are insufficient for the treatment of cardiogenic shock refractory to inotropic support, thereby minimizing the detrimental effect of catecholamines.

[1]  A. Michelucci,et al.  Cardiac Resynchronization Therapy Acutely Improves Ventricular‐Arterial Coupling by Reducing the Arterial Load: Assessment by Pressure–Volume Loops , 2015, Pacing and clinical electrophysiology : PACE.

[2]  Richard Beale,et al.  Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine , 2014, Intensive Care Medicine.

[3]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.

[4]  N. Senguttuvan,et al.  Cardiac resynchronization therapy for critically ill patients with left ventricular systolic dysfunction. , 2013, International journal of cardiology.

[5]  M. Link,et al.  2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2012, The Journal of thoracic and cardiovascular surgery.

[6]  M. Link,et al.  2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2012, Journal of the American College of Cardiology.

[7]  R. Pearse,et al.  Use of inotropes and vasopressor agents in critically ill patients , 2012, British journal of pharmacology.

[8]  Jeroen J. Bax,et al.  Cardiac Resynchronization Therapy as a Therapeutic Option in Patients With Moderate-Severe Functional Mitral Regurgitation and High Operative Risk , 2011, Circulation.

[9]  J. Burkhardt,et al.  Impact of cardiac resynchronization therapy on the severity of mitral regurgitation. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[10]  T. Naqvi Echocardiography-guided biventricular pacemaker optimization. , 2010, JACC. Cardiovascular imaging.

[11]  Surya M. Artham Feigenbaum's Echocardiography , 2010 .

[12]  T. Naqvi,et al.  Biventricular pacemaker optimization guided by comprehensive echocardiography-preliminary observations regarding the effects on systolic and diastolic ventricular function and third heart sound. , 2010, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[13]  J. Takala,et al.  Hemodynamic variables and mortality in cardiogenic shock: a retrospective cohort study , 2009, Critical care.

[14]  S. Barold,et al.  Echocardiographic optimization of the atrioventricular and interventricular intervals during cardiac resynchronization. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[15]  Jeroen J. Bax,et al.  Results of the Predictors of Response to CRT (PROSPECT) Trial , 2008, Circulation.

[16]  G. Sutherland,et al.  Patient Selection and Echocardiographic Assessment of Dyssynchrony in Cardiac Resynchronization Therapy , 2008, Circulation.

[17]  A. Cohen-Solal,et al.  Cardiac resynchronisation as a rescue therapy in patients with catecholamine‐dependent overt heart failure: Results from a short and mid‐term study , 2008, European journal of heart failure.

[18]  M. Singer Catecholamine treatment for shock—equally good or bad? , 2007, The Lancet.

[19]  Alex Pui-Wai Lee,et al.  Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography. , 2006, Journal of the American College of Cardiology.

[20]  A. Battler,et al.  Urgent Cardiac Resynchronization Therapy in Patients with Decompensated Chronic Heart Failure Receiving Inotropic Therapy , 2006, Cardiology.

[21]  Angelo Auricchio,et al.  Cardiac resynchronization therapy in heart failure. , 2005, Italian heart journal : official journal of the Italian Federation of Cardiology.

[22]  M. Henein,et al.  Limitation of exercise tolerance in chronic heart failure: distinct effects of left bundle-branch block and coronary artery disease. , 2004, Journal of the American College of Cardiology.

[23]  Catherine Klersy,et al.  Interventricular and intraventricular dyssynchrony are common in heart failure patients, regardless of QRS duration. , 2004, European heart journal.

[24]  M. Henein,et al.  Electromechanical interrelations during dobutamine stress in normal subjects and patients with coronary artery disease: comparison of changes in activation and inotropic state , 2001, Heart.

[25]  Biykem Bozkurt,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.

[26]  B. Wilkoff,et al.  Biventricular pacing for heart failure patients on inotropic support: a review of 38 consecutive cases. , 2006, Texas Heart Institute journal.

[27]  M. Henein,et al.  Limitation of cardiac output by total isovolumic time during pharmacologic stress in patients with dilated cardiomyopathy: activation-mediated effects of left bundle branch block and coronary artery disease. , 2003, Journal of the American College of Cardiology.